Global Antiretroviral Drugs Market Size, Share, Trends, and Growth factors, Top Key Players, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024
Global Antiretroviral Drugs Market report offers Market Size, Dynamics, Regional Market Share, Top Key Players, Latest trends, Growth factors, Industry Stats, Historic Market, Business Intelligence, Business Research Reports, Competitive Intelligence 2013 to 2017 and Forecast 2018 to 2024
Cytopathic effects in cells in the brain and infected T cells may develop immune deficiencies and neurological diseases induced by HIV and related lentiviruses. Retrovirus causes immunological diseases including HIV and T-Cell leukaemia. Acquired immune deficiency syndrome (AIDS) caused by retrovirus known as human immunodeficiency virus (HIV) and T-Cell leukaemia caused by human T lymphotropic virus (HTLV). Antiretroviral drugs are the drugs that acts or inhibit certain process in viral replication and inhibits further worsening of the diseases.
Globally antiretroviral drugs market driven by increased cases of retroviral infections such as especially HIV/AIDS. According to WHO, 36.7 million people were diagnosed with HIV/AIDS in 2015, whereas, 1.1 million people died of AIDS related illness in the same year. The higher prevalence of HIV owing to the various factors such as lack of availability of medication for the treatment of HIV infection, promising pipeline drugs, increased funding by the government are expected to bolster the antiretroviral drugs market over the forecast period. However, high costs of R&D and stringent regulatory procedures hampering the antiretroviral drugs market. Furthermore, availability of the generic versions of blockbuster drugs affecting the market revenue of antiretroviral drugs.
A sample of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-4H8Z4LpNMLEuOnnx
Global antiretroviral drugs market is segmented based on drug class, route of administration, and distribution channel
Based on drug class, antiretroviral drugs are classified into
• Nucleoside Reverse Transcriptase Inhibitors (NRT’s)
• Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT’s)
• Protease Inhibitors
• Integrate Inhibitors
• Fusion Inhibitors
• Chemokine Receptor Inhibitors
• Others
Based on route of administration, antiretroviral drugs are classified into
• Oral
• Parenteral
Based on distribution channel, antiretroviral drugs market is classified into
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
To view TOC of this report is available upon request @
https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-4H8Z4LpNMLEuOnnx
Antiretroviral drugs market is expected to grow at significant rates during forecasting period owing to pipeline drugs such as doravirine (Merck & Co.), fostemsavir (Bristol-Myers Squibb), rilpivirine (Tibotec) etc. Market players are adopting strategies like mergers and acquisitions to improve the market share. In December 2015, ViiV Healthcare purchased Bristol-Myers Squibb’s late stage HIV R&D assets. Market players are also actively collaborating with government and non-government organizations to educate the people and increase awareness related to retroviral diseases. For instance, in September 2016, in an effort to eradicate and combat HIV/AIDS and hypertension in Africa, under U.S. Presidents Emergency Plan for Aids Relief (PEPFAR), United States partnered with AstraZeneca Plc in donating US$10 million to HIV/AIDS funding.
Need more information about this report @
https://www.precisionbusinessinsights.com/market-reports/global-antiretroviral-drugs-market/#ulp-14mlyhjMGhVjZqa3
Some of the players in the antiretroviral drugs market are Abbott Laboratories (U.S.), AstraZeneca plc (U.K.), Modified Polymer Components, Inc. (Bristol-Myers-Squibb) (U.S), Gilead Sciences (U.S.), GlaxoSmithKline Plc (U.K.), and F. Hoffmann-La Roche AG (Switzerland) to name a few.
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 – 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @ https://www.precisionbusinessinsights.com